Eyenovia, Inc. Email Format
Pharmaceutical ManufacturingNew York, United States11-50 Employees
Eyenovia, Inc. is a New York-based ophthalmic technology company focused on drug-delivery solutions for eye care. It develops the Optejet device to be used with its own drug-device therapeutic candidates addressing presbyopia and pediatric progressive myopia. The company also pursues out-licensing opportunities to apply its delivery platform to additional indications. Its target customers are eye care professionals and patients seeking delivery options for presbyopia and pediatric progressive myopia, with the aim of improving treatment accuracy and convenience through device-assisted therapy. Positioned in the pharmaceutical manufacturing and ophthalmic technology sectors, Eyenovia combines its delivery platform with drug candidates and pursues licensing collaborations to expand its reach. In recent developments, the company has begun exploring digital assets, including the launch of a co-branded validator node on the Hyperliquid blockchain.